中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共9条，第1-9条

帮助

条数/页：排序方式：
	Design and evaluation of cyanocobalamin nasal powders for nasal delivery using biomimetic nasal cavity models 期刊论文 OAI收割 JOURNAL OF PHARMACEUTICAL SCIENCES, 2025, 卷号: 114, 期号: 11, 页码: 13 作者: Lv, Yuting; Li, Zeru; Wu, Qian; Peng, Ningning; Gao, Qingfang \| 收藏 \| 浏览/下载：3/0 \| 提交时间：2025/12/04 Vitamin B12 Hydroxypropyl-beta-cyclodextrin Nasal powder Nasal drug delivery Powder technology Nasal cavity model 3D Printing Nasal absorption Bioavailability
	Supersaturated polymeric micelles for oral silybin delivery: the role of the Soluplus-PVPVA complex 期刊论文 OAI收割 ACTA PHARMACEUTICA SINICA B, 2019, 卷号: 9, 期号: 1, 页码: 107-117 作者: Zhu, Chunliu; Gong, Shuang; Ding, Jinsong; Yu, Miaorong; Ahmad, Ejaj \| 收藏 \| 浏览/下载：149/0 \| 提交时间：2020/07/01 Silybin Soluplus PVPVA Complex Supersaturated drug delivery system Oral bioavailability
	effectsofanal3andmg2containingantacidferroussulfateandcalciumcarbonateontheabsorptionofnemonoxacintg873870inhealthychinesevolunteers 期刊论文 OAI收割 actapharmacologicasinica, 2014, 卷号: 35, 期号: 12, 页码: 1586 作者: Zhang Yifan; Dai Xiaojian; Wang Ting; Chen Xiaoyan; Li Liang \| 收藏 \| 浏览/下载：39/0 \| 提交时间：2020/07/01 NON-FLUORINATED QUINOLONE CIPROFLOXACIN GATIFLOXACIN PHARMACOKINETICS BIOAVAILABILITY ALUMINUM SAFETY SLEEP nemonoxacin nonfluorinated quinolone drug-drug interaction antacid ferrous sulfate calcium carbonate drug absorption clinical pharmacokinetics
	Novel pH-sensitive lipid-polymer composite microspheres of 10-hydroxycamptothecin exhibiting colon-specific biodistribution and reduced systemic absorption 期刊论文 OAI收割 JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 卷号: 102, 期号: 6, 页码: 1752-1759 作者: Gan, Li; Gao, Yi-Ping; Zhu, Chun-Liu; Zhang, Xin-Xin; Gan, Yong \| 收藏 \| 浏览/下载：126/0 \| 提交时间：2019/01/08 colonic drug delivery polymers lipids pH-sensitive 10-hydroxycamptothecin microspheres biodistribution bioavailability
	A high-drug-loading self-assembled nanoemulsion enhances the oral absorption of probucol in rats 期刊论文 OAI收割 JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 卷号: 102, 期号: 4, 页码: 1301-1306 作者: Zhang, Zhiwen; Huang, Jian; Jiang, Shijun; Liu, Zeying; Gu, Wangwen \| 收藏 \| 浏览/下载：104/0 \| 提交时间：2019/01/08 nanoemulsion self-assembly bioavailability poorly water-soluble drug probucol intestinal absorption pharmacokinetics calorimetry (DSC) oral drug delivery
	Investigation on in situ Gel Based on Liposomal Vesicle 期刊论文 OAI收割 chemical journal of chinese universities-chinese, 2013, 卷号: 34, 期号: 5, 页码: 1174-1179 Guan QX; Lu JW; Guo J; Ning ZL; Chen C; Yin JY 收藏 \| 浏览/下载：49/0 \| 提交时间：2014/04/15 DRUG-DELIVERY ENHANCED BIOAVAILABILITY OCULAR DELIVERY RELEASE LUTEIN NANOVESICLES
	Simulation of the pharmacokinetics of bisoprolol in healthy adults and patients with impaired renal function using whole-body physiologically based pharmacokinetic modeling 期刊论文 OAI收割 ACTA PHARMACOLOGICA SINICA, 2012, 卷号: 33, 期号: 11, 页码: 1359 作者: Li Guofu; Wang Kun; Chen Rui; Zhao Haoru; Yang Jin \| 收藏 \| 浏览/下载：44/0 \| 提交时间：2020/12/24 TISSUE DISTRIBUTION DRUG DISCOVERY INTRASUBJECT VARIABILITY PBPK SIMULATION P-GP ABSORPTION POPULATION PREDICTION BIOAVAILABILITY IDENTIFICATION bisoprolol whole-body physiologically based pharmacokinetic model drug absorption drug distribution renal function impairment
	Oral bioavailability and brain penetration of (-)-stepholidine, a tetrahydroprotoberberine agonist at dopamine D-1 and antagonist at D-2 receptors, in rats 期刊论文 OAI收割 BRITISH JOURNAL OF PHARMACOLOGY, 2009, 卷号: 158, 期号: 5, 页码: 1302-1312 作者: Sun, Yan; Dai, Jieyu; Hu, Zheyi; Du, Feifei; Niu, Wei \| 收藏 \| 浏览/下载：130/0 \| 提交时间：2019/01/08 (-)-stepholidine CNS drug enterohepatic barrier blood-brain barrier oral bioavailability brain penetration metabolic profiling prodrug
	Enhanced circulation half-life of site-specific PEGylated rhG-CSF: Optimization of PEG molecular weight 期刊论文 OAI收割 JOURNAL OF BIOTECHNOLOGY, 2009, 卷号: 142, 期号: 3-4, 页码: 259-266 作者: Zhai, Yanqin; Zhao, Yongjiang; Lei, Jiandu; Su, Zhiguo; Ma, Guanghui 收藏 \| 浏览/下载：144/0 \| 提交时间：2013/12/06 Drug bioavailability Granulocyte colony stimulating factor (G-CSF) Serum half-life Site-specific PEGylation